Metropolitan Life Insurance Company (MetLife)’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-5,703
| Closed | -$152K | – | 2548 |
|
|
2015
Q4 | $152K | Buy |
5,703
+19
| +0.3% | +$506 | ﹤0.01% | 2428 |
|
|
2015
Q3 | $259K | Buy |
5,684
+811
| +17% | +$37K | ﹤0.01% | 2102 |
|
|
2015
Q2 | $157K | Sell |
4,873
-1,701
| -26% | -$54.8K | ﹤0.01% | 2528 |
|
|
2015
Q1 | $209K | Sell |
6,574
-29
| -0.4% | -$922 | ﹤0.01% | 2036 |
|
|
2014
Q4 | $250K | Hold |
6,603
| – | – | ﹤0.01% | 2247 |
|
|
2014
Q3 | $174K | Buy |
6,603
+6,516
| +7,490% | +$172K | ﹤0.01% | 2480 |
|
|
2014
Q2 | $3K | Sell |
87
-5,013
| -98% | -$173K | ﹤0.01% | 2765 |
|
|
2014
Q1 | $189K | Hold |
5,100
| – | – | ﹤0.01% | 2500 |
|
|
2013
Q4 | $211K | Hold |
5,100
| – | – | ﹤0.01% | 2433 |
|
|
2013
Q3 | $270K | Buy |
5,100
+2,609
| +105% | +$138K | ﹤0.01% | 2189 |
|
|
2013
Q2 | $133K | Buy |
+2,491
| New | +$133K | ﹤0.01% | 2619 |
|